Literature DB >> 21263191

Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells.

Andreas Sponring1, Wojciech Filipiak, Clemens Ager, Jochen Schubert, Wolfram Miekisch, Anton Amann, Jakob Troppmair.   

Abstract

Analysis of volatile organic compounds (VOCs) provides an elegant approach for cancer screening and disease monitoring, whose use is currently limited by a lack of validated cancer-derived metabolites, which may serve as biomarkers. The aim of the experiments presented here was to investigate the release and consumption of VOCs from the non small cell lung cancer cell line NCI-H1666, which was originally derived from a bronchoalveolar carcinoma.Following detachment by trypsinization suspended cells were incubated in a sealed fermenter for 21 hours. 200 ml of headspace from the cell culture were sampled, diluted with dry, highly purified air and preconcentrated by adsorption on three different solid sorbents with increasing adsorption strength. VOC-analysis was performed by thermodesorption-gas chromatography mass spectrometry (TD-GC-MS). In contrast to our previous studies experiments with NCI-H1666 cells only confirmed the consumption of several aldehydes, n-butyl acetate and the ethers methyl tert-butyl ether and ethyl tert-butyl ether, but no unequivocal release of VOCs was observed. Together with our previously published work these data indicate that the consumption of certain VOCs is commonly observed while their release shows cell line-restricted patterns, whose underlying causes are unknown.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21263191     DOI: 10.3233/CBM-2010-0182

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  25 in total

1.  Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.

Authors:  W Filipiak; V Ruzsanyi; P Mochalski; A Filipiak; A Bajtarevic; C Ager; H Denz; W Hilbe; H Jamnig; M Hackl; A Dzien; A Amann
Journal:  J Breath Res       Date:  2012-09       Impact factor: 3.262

2.  Progress in the development of volatile exhaled breath signatures of lung cancer.

Authors:  Peter J Mazzone; Xiao-Feng Wang; Sung Lim; James Jett; Humberto Choi; Qi Zhang; Mary Beukemann; Meredith Seeley; Ray Martino; Paul Rhodes
Journal:  Ann Am Thorac Soc       Date:  2015-05

3.  GC/MS-based Analysis of Volatile Metabolic Profile Along in vitro Differentiation of Human Induced Pluripotent Stem Cells.

Authors:  Rosamaria Capuano; Rosa Valentina Talarico; Paola Spitalieri; Roberto Paolesse; Giuseppe Novelli; Federica Sangiuolo; Corrado Di Natale
Journal:  Bio Protoc       Date:  2017-12-05

4.  Classification of lung cancer histology by gold nanoparticle sensors.

Authors:  Orna Barash; Nir Peled; Ulrike Tisch; Paul A Bunn; Fred R Hirsch; Hossam Haick
Journal:  Nanomedicine       Date:  2011-10-25       Impact factor: 5.307

5.  Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.

Authors:  Anton Amann; Pawel Mochalski; Vera Ruzsanyi; Yoav Y Broza; Hossam Haick
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

6.  Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Wojciech Filipiak; Andreas Sponring; Maria Magdalena Baur; Anna Filipiak; Clemens Ager; Helmut Wiesenhofer; Markus Nagl; Jakob Troppmair; Anton Amann
Journal:  BMC Microbiol       Date:  2012-06-20       Impact factor: 3.605

7.  Blood and breath profiles of volatile organic compounds in patients with end-stage renal disease.

Authors:  Paweł Mochalski; Julian King; Matthias Haas; Karl Unterkofler; Anton Amann; Gert Mayer
Journal:  BMC Nephrol       Date:  2014-03-08       Impact factor: 2.388

Review 8.  Assessment, origin, and implementation of breath volatile cancer markers.

Authors:  Hossam Haick; Yoav Y Broza; Pawel Mochalski; Vera Ruzsanyi; Anton Amann
Journal:  Chem Soc Rev       Date:  2013-12-04       Impact factor: 54.564

9.  Volatile fingerprints of cancer specific genetic mutations.

Authors:  Nir Peled; Orna Barash; Ulrike Tisch; Radu Ionescu; Yoav Y Broza; Maya Ilouze; Jane Mattei; Paul A Bunn; Fred R Hirsch; Hossam Haick
Journal:  Nanomedicine       Date:  2013-02-18       Impact factor: 5.307

10.  Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.

Authors:  Paweł Mochalski; Andreas Sponring; Julian King; Karl Unterkofler; Jakob Troppmair; Anton Amann
Journal:  Cancer Cell Int       Date:  2013-07-17       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.